FDA 483 OBSERVATION · #410 OF 1,932 MOST-CITED

Eligibility not required--warning labels

FDA cited this observation 63 times across 55 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Human Tissue for Transplantation63
BY FISCAL YEAR
FY20261
FY20259
FY202412
FY20237
FY20227
FY20216
FY20204
FY20198
FY20184
FY20171
FY20164

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 1.9× the rate of the average FDA-cited firm (14.5% vs 7.8%), across 55 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

HCT/Ps for which the donor eligibility determination was not required were not prominently labeled with the appropriate warning statements.

Reproductive Medicine Institute · Oak Brook, Illinois · Human Tissue for Transplantation · 2026-06-09

HCT/Ps for which the donor eligibility determination was not required were not prominently labeled with the appropriate warning statements.

University of Chicago Hospitals · Chicago, Illinois · Human Tissue for Transplantation · 2025-07-17

HCT/Ps for which the donor eligibility determination was not required were not prominently labeled with the appropriate warning statements.

Arizona Reproductive Medicine Specialists · Phoenix, Arizona · Human Tissue for Transplantation · 2025-06-30

HCT/Ps for which the applicable donor eligibility requirements were not met were not prominently labeled with the appropriate warning statements.

Ohio Fertility Providers LLC · Cincinnati, Ohio · Human Tissue for Transplantation · 2025-05-15

HCT/Ps for which the donor eligibility determination was not required and applicable donor eligibility requirements were not met were not prominently labeled with the appropriate warning statements.

Fort Worth Fertility P.A. · Fort Worth, Texas · Human Tissue for Transplantation · 2025-04-24

HCT/Ps for which the donor eligibility determination was not required and applicable donor eligibility requirements were not met were not prominently labeled with the appropriate warning statements.

Kofinas Fertility Group · New York, New York · Human Tissue for Transplantation · 2025-04-09

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →